Showing results (2571-2580 of 2,889) with videos related to
Sort By:
Pageof 289
Molecular Diversity|July 8, 2016
Design, synthesis, insecticidal activity, and structure-activity relationship (SAR): studies of novel triazone derivatives containing a urea bridge group based on transient receptor potential (TRP) channelsYan Yang, Yuxiu Liu, Hongjian Song, et al.Molecular Diversity|June 29, 2016
Advancements in tetronic acid chemistry. Part 2: Use as a simple precursor to privileged heterocyclic motifsMoaz M Abdou, Rasha A El-Saeed, Khaled M Elattar, et al.Molecular Diversity|July 14, 2017
Synthesis of α-amino-1,3-dicarbonyl compounds via Ugi flow chemistry reaction: access to functionalized 1,2,3-triazolesStanley N S Vasconcelos, Evelin Fornari, Ignez Caracelli, et al.Molecular Diversity|January 5, 2018
Synthesis and structure-activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agentsLongjia Yan, Hui Wang, Yunpeng Chen, et al.Molecular Diversity|November 25, 2020
Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatmentLuminita Crisan, Daniela Istrate, Alina Bora, et al.Molecular Diversity|November 5, 2020
[TBP]2SO4 ionic liquid catalyst for 4MCR of pyridazinoindazole, indazolophthalazine and pyrazolophthalazine derivativesNajmeh Amirmahani, Nosrat O Mahmoodi, Mohammad Malakootian, et al.Molecular Diversity|September 10, 2020
Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approachChonny Herrera-Acevedo, Mayara Dos Santos Maia, Élida Batista Vieira Sousa Cavalcanti, et al.Molecular Diversity|June 23, 2022
Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approachHezha O Rasul, Bakhtyar K Aziz, Dlzar D Ghafour, et al.Molecular Diversity|June 23, 2022
In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J)Konstantinos G KalamatianosMolecular Diversity|December 30, 2022
Catalyst-free synthesis of highly functionalized triazole hexahydroquinoline carbohydrazide scaffolds via four-component cyclocondensation reactionHasti Amorzesh, Mohammad Bayat, Shima NasriPageof 289